Latest News about Psychedelics Research
Recent news which mentions Psychedelics Research
UK Breaks New Ground With First Government-Backed Psilocybin Therapy For Opioid Crisis
November 07, 2024
From Benzinga
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
November 06, 2024
From Benzinga
Americans Favor Psilocybin For Mental Health Treatment, Study Finds
November 05, 2024
From Benzinga
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
October 31, 2024
From Benzinga
From Benzinga
Psychedelic Drug DOI Pinpoints Anxiety Circuits Avoiding Hallucinogenic Effects, Study Finds
October 28, 2024
Tickers
NEWS
From Benzinga
From Benzinga
How Psychedelic Experiences Affect Couples: New Study Looks Into It
October 17, 2024
Tickers
MDMA
From Benzinga
From Benzinga
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis
October 17, 2024
From Benzinga
Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy
October 15, 2024
From Benzinga
From Benzinga
The Optimism Experiment: Psilocybin's Impact On Motivation
October 10, 2024
Tickers
NEWS
From Benzinga
Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
September 27, 2024
From Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
September 26, 2024
From Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
From Benzinga
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
September 24, 2024
Tickers
NEWS
From Benzinga
Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences
April 29, 2024
Tickers
NEWS
From Benzinga
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
April 17, 2024
From Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
From Benzinga
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
April 15, 2024
From Benzinga
From Benzinga
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
April 05, 2024
From Benzinga
From Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
March 29, 2024
From Benzinga
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
March 29, 2024
From Benzinga
From Benzinga
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
March 27, 2024
Tickers
MDXXF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.